Siwei Li - Publications

Affiliations: 
2008-2014 Chemistry University of Cincinnati, Cincinnati, OH 
Area:
Metabolomics, Clinical Mass Spectrometry, Drug Metabolism

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Huddle BC, Grimley E, Chtcherbinine M, Buchman CD, Takahashi C, Debnath B, McGonigal SC, Mao S, Li S, Felton J, Pan S, Wen B, Sun D, Neamati N, Buckanovich RJ, et al. Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy. European Journal of Medicinal Chemistry. 211: 113060. PMID 33341649 DOI: 10.1016/j.ejmech.2020.113060  0.413
2018 Huddle BC, Grimley E, Buchman CD, Chtcherbinine M, Debnath B, Mehta P, Yang K, Morgan CA, Li S, Felton JA, Sun D, Metha G, Neamati N, Buckanovich RJ, Hurley TD, et al. Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. Journal of Medicinal Chemistry. PMID 30221940 DOI: 10.1021/Acs.Jmedchem.8B00930  0.462
2018 Qin C, Hu Y, Zhou B, Fernandez-Salas E, Yang CY, Liu L, McEachern D, Przybranowski S, Wang M, Stuckey J, Meagher J, Bai L, Chen Z, Lin M, Yang J, ... ... Li S, et al. Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression. Journal of Medicinal Chemistry. PMID 30019901 DOI: 10.1021/Acs.Jmedchem.8B00506  0.458
2018 Zhao Y, Zhou B, Bai L, Liu L, Yang CY, Meagher JL, Stuckey JA, McEachern D, Przybranowski S, Wang M, Ran X, Aguilar A, Hu Y, Kampf JW, Li X, ... ... Li S, et al. Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor. Journal of Medicinal Chemistry. PMID 30015487 DOI: 10.1021/Acs.Jmedchem.8B00483  0.471
2017 Zhao Y, Bai L, Liu L, McEachern D, Stuckey JA, Meagher JL, Yang CY, Ran X, Zhou B, Hu Y, Li X, Wen B, Zhao T, Li S, Sun D, et al. Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor. Journal of Medicinal Chemistry. PMID 28463487 DOI: 10.1021/Acs.Jmedchem.7B00193  0.472
2016 Yu A, Baker JR, Fioritto AF, Wang Y, Luo R, Li S, Wen B, Bly M, Tsume Y, Koenigsknecht MJ, Zhang X, Lionberger R, Amidon GL, Hasler WL, Sun D. Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract. Molecular Pharmaceutics. PMID 28009518 DOI: 10.1021/Acs.Molpharmaceut.6B00641  0.53
2016 Patel TS, Cinti S, Sun D, Li S, Luo R, Wen B, Gallagher BA, Stevenson JG. Oseltamivir for pandemic influenza preparation: Maximizing the use of an existing stockpile. American Journal of Infection Control. PMID 27816215 DOI: 10.1016/J.Ajic.2016.09.024  0.401
2016 Fioritto AF, Yu A, Baker J, Collins K, Wen B, Wang Y, Luo R, Li S, Bleske B, Johnson M, Koenigsknecht M, Hasler WL, Sun D. Mo1318 Direct Comparison of In Vivo Drug Release Profiles of Three Locally-Acting Drug Products of Mesalamine in the Gastrointestinal Tract and Correlation With Systemic Exposure and Fecal Concentrations in Healthy Humans Gastroenterology. 150: S696. DOI: 10.1016/S0016-5085(16)32375-7  0.431
2014 Li S, Limbach PA. Identification of RNA sequence isomer by isotope labeling and LC-MS/MS. Journal of Mass Spectrometry : Jms. 49: 1191-8. PMID 25395135 DOI: 10.1002/Jms.3449  0.522
2014 Wetzel C, Li S, Limbach PA. Metabolic de-isotoping for improved LC-MS characterization of modified RNAs. Journal of the American Society For Mass Spectrometry. 25: 1114-23. PMID 24760295 DOI: 10.1007/S13361-014-0889-9  0.535
2013 Li S, Limbach PA. Mass spectrometry sequencing of transfer ribonucleic acids by the comparative analysis of RNA digests (CARD) approach. The Analyst. 138: 1386-94. PMID 23295341 DOI: 10.1039/C2An36515D  0.514
2012 Li S, Limbach PA. Method for comparative analysis of ribonucleic acids using isotope labeling and mass spectrometry. Analytical Chemistry. 84: 8607-13. PMID 22985222 DOI: 10.1021/Ac301638C  0.524
Show low-probability matches.